Research Topics
Genomes and Genes | P L McGeerSummaryAffiliation: University of British Columbia Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Innate immunity, local inflammation, and degenerative diseasePatrick L McGeer
Kinsmen Laboratory of Neurological Research at the University of British Columbia, Vancouver, BC, V6T 1Z3, Canada
Sci Aging Knowledge Environ 2002:re3. 2002..NSAIDs inhibit the production of prostaglandin inflammatory mediators, but powerful new therapeutic agents might be developed by targeting more critical inflammatory mechanisms, especially the complement system...
Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosisJudith Miklossy
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, BC, Canada
J Neuroinflammation 5:40. 2008..We investigated whether a similar situation may occur in Lyme neuroborreliosis...
Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's diseaseAnastazija Gnjec
Centre of Excellence for Alzheimer s Disease Research and Care, Faculty of Computing, Health and Science, School of Exercise, Biomedical and Health Sciences, Edith Cowan University, Joondalup, 6027, WA, Australia
J Neuroinflammation 5:36. 2008..In the current study TNFA and BAT1 promoter polymorphisms were analysed in AD and control cases and BAT1 mRNA levels were investigated in brain tissue from AD and control cases...
Autotoxicity and Alzheimer diseaseP L McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, British Columbia, Canada V6T 1Z3
Arch Neurol 57:789-90. 2000..Even in vertebrates, however, the innate immune system is the first line of defense. Much more needs to be learned about the operation of the innate immune system in health and disease. Arch Neurol. 2000...
Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrationPatrick L McGeer
Kinsmen Laboratory of Neurological Research, Division of Neurology, University of British Columbia, Vancouver, BC, Canada V6T 1Z3
Ann Neurol 54:599-604. 2003..The mechanism is unknown but could have important implications regarding the cause of Parkinson's disease and possible approaches to therapy...
Local neuroinflammation and the progression of Alzheimer's diseasePatrick L McGeer
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
J Neurovirol 8:529-38. 2002....
Expression of COX-1 and COX-2 mRNAs in atherosclerotic plaquesPatrick L McGeer
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, Canada V6T 1Z3
Exp Gerontol 37:925-9. 2002..Accordingly, COX-2 inhibitors may reduce the degree of inflammation and protect against future cardiovascular events...
Association of interleukin-1 beta polymorphisms with idiopathic Parkinson's diseasePatrick L McGeer
Kinsmen Laboratory of Neurological Research and the Movement Disorders Center, University of British Columbia, Vancouver, B C, Canada
Neurosci Lett 326:67-9. 2002..65, P=0.0019). A significant increase was not found for the IL-alpha T genotype (chi(2)=1.32, P=0.23), although there was a trend towards more frequent expression of the T allele...
Inflammation, autotoxicity and Alzheimer diseaseP L McGeer
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, Vancouver, B C, Canada
Neurobiol Aging 22:799-809. 2001..Inhibitors of mediators closer to the core processes might offer even greater therapeutic promise. Some theoretical opportunities are suggested, based on intervention in the action of the above mentioned mediators...
Brain inflammation in Alzheimer disease and the therapeutic implicationsE G McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, B C, V6T 1Z3, Canada
Curr Pharm Des 5:821-36. 1999..The complement system, microglia and cytokines are key components. This review summarizes the present state of knowledge on the immune system elements found in AD brain...
Polymorphisms in inflammatory genes and the risk of Alzheimer diseaseP L McGeer
Department of Psychiatry, University of British Columbia, Vancouver, Canada
Arch Neurol 58:1790-2. 2001..Such information could lead to strategies for therapeutic intervention in the early stages of such disorders...
Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's diseaseP L McGeer
Department of Psychiatry, University of British Columbia, Vancouver, Canada
Drugs Aging 17:1-11. 2000..These results emphasise that the appropriate target for NSAID trials in AD is COX-1, but they also indicate that there would be no contraindication to the use of those traditional NSAIDs which have mixed COX-1/COX-2 inhibiting activity...
Immunotherapy for Alzheimer's diseasePatrick L McGeer
Kinsmen Laboratory of Neurological Research at the University of British Columbia, Vancouver, BC V6T 1Z3, Canada
Sci Aging Knowledge Environ 2004:pe29. 2004..Because both pro- and anti-inflammatory activation of immune cells are possible, stimulating the phagocytic action of microglia while simultaneously stimulating anti-inflammatory activity might be beneficial in AD...
The alpha-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer diseasePatrick L McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, B.C, Canada V6T 1Z3
Exp Neurol 212:235-8. 2008
Glial reactions in Parkinson's diseasePatrick L McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, British Columbia, Canada
Mov Disord 23:474-83. 2008..Further research concerning glial reactions in PD may lead to disease-modifying therapeutic approaches...
Inflammation and the degenerative diseases of agingPatrick L McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada
Ann N Y Acad Sci 1035:104-16. 2004..Thus, full therapeutic doses of NSAIDs, or combinations of anti-inflammatory agents, are needed to achieve the suggested neurological benefits...
NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studiesPatrick L McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, BC, Canada
Neurobiol Aging 28:639-47. 2007..Further clinical investigations with relatively high doses of traditional NSAIDs might be warranted, although significant side effects should be anticipated...
Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 yearsPatrick L McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver BC, Canada
J Alzheimers Dis 9:271-6. 2006..Future directions should include a search for other inflammatory mediators in AD and exploitation of current knowledge to improve available treatments...
The ALS/PDC syndrome of Guam: potential biomarkers for an enigmatic disorderPatrick L McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, BC, Canada
Prog Neurobiol 95:663-9. 2011..Identification of biomarkers for premortem diagnosis would be helpful in management as well as in revealing the true etiology...
Immunohistochemical analyses of fibroblast growth factor receptor-1 in the human substantia nigra. Comparison between normal and Parkinson's disease casesD G Walker
Kinsmen Laboratory of Neurological Research, Department of Psychiatry and Neurodegenerative Disease Centre, University of British Columbia, Vancouver, British Columbia, Canada
Brain Res 794:181-7. 1998..FGFR-1 immunoreactivity was also detected in many of the residual SN neurons in most of the idiopathic PD cases. These results indicate that FGFR-1 immunoreactivity, and possibly FGF binding activity, is retained in DA neurons in PD...
Induction of complement C9 messenger RNAs in human neuronal cells by inflammatory stimuli: relevance to neurodegenerative disordersA Klegeris
Department of Psychiatry, Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, Canada V6T 1Z3
Exp Gerontol 36:1179-88. 2001....
Tetrahydroaminoacridine potentiates neurotoxicity of quinolinic acid in rat striatumS G Zhu
Department of Psychiatry, University of British Columbia, Vancouver, Canada
Neurosci Lett 95:252-6. 1988..A larger dose (10 mg/kg) THA had no significant effect. The results are discussed in terms of THA's binding to various elements of the NMDA/sigma receptor complex and reported data on such binding are confirmed...
Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeysJ Miklossy
Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, Canada V6T1Z3
Exp Neurol 197:275-83. 2006..The presence of ICAM-1-positive reactive astrocytes in Parkinson disease and MPTP-treated monkeys is indicative of a sustained inflammatory process and suggests that antiinflammatory agents may have a place in PD therapy...
3-hydroxy-3-methylglutaryl-coenzyme A reductase mRNA in Alzheimer and control brainK Yasojima
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada
Neuroreport 12:2935-8. 2001..We conclude that brain has a robust capacity to synthesize cholesterol which appears to be unaffected by AD pathology...
Inflammatory cytokine levels are influenced by interactions between THP-1 monocytic, U-373 MG astrocytic, and SH-SY5Y neuronal cell lines of human originA Klegeris
Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada
Neurosci Lett 313:41-4. 2001....
Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicityAndis Klegeris
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, BC, Canada V6T 1Z3
Neurobiol Aging 23:787-94. 2002....
Generation of C-reactive protein and complement components in atherosclerotic plaquesK Yasojima
Department of Psychiatry, Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, British Columbia V6T 1Z3 Canada
Am J Pathol 158:1039-51. 2001..Because CRP is a complement activator, and activated complement attacks cells in plaque tissue, these data provide evidence of a self-sustaining autotoxic mechanism operating within the plaques as a precursor to thrombotic events...
Regulation of glutamate in cultures of human monocytic THP-1 and astrocytoma U-373 MG cellsA Klegeris
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada
J Neuroimmunol 78:152-61. 1997..These data indicate that inflammatory stimuli may increase extracellular glutamate while antiinflammatory drugs decrease it...
Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's diseaseD G Walker
Kinsmen Laboratory of Neurological Research and Neurodegenerative Disease Centre, University of British Columbia, Vancouver, BC, Canada
Brain Res 792:207-17. 1998..Ret expression by microglia was confirmed by immunoblot analysis on the human THP-1 macrophage type cell line. However, these cells did not express the mRNA for GDNFRalpha, the other component of the GDNF receptor complex...
High stability of mRNAs postmortem and protocols for their assessment by RT-PCRK Yasojima
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, Canada V6T 1Z3
Brain Res Brain Res Protoc 8:212-8. 2001..Reliable mRNA values may be obtained from postmortem brain with long autolysis times provided the tissue has been kept in the cold, and from frozen tissues for 1-2 h after thawing...
Effect of MK-801, kynurenate, glycine, dextrorphan and 4-acetylpyridine on striatal toxicity of quinolinateS G Zhu
Department of Psychiatry, University of British Columbia, Vancouver, Canada
Brain Res 481:356-60. 1989..Glycine appeared to potentiate the effect of high doses of quinolinic acid on ChAT and the other pretreatments tested (dextrorphan, dextromethorphan, 4-acetylpyridine) had no significant effect...
Interleukin 1alpha and interleukin 6 protect human neuronal SH-SY5Y cells from oxidative damageChristopher J Bissonnette
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, BC, Canada
Neurosci Lett 361:40-3. 2004..These data indicate that IL-1alpha and IL-6 can, under appropriate circumstances, protect neurons from oxidative damage in addition to their well-known action of stimulating inflammation...
Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC)Judith Miklossy
Kinsmen Laboratory of Neurological Research, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada
Acta Neuropathol 116:625-37. 2008..The results obtained may help to define the commonality of the Guam disease with other tangle forming disorders and may help in monitoring the epidemiological changes that are taking place...
Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer diseaseClaudia Schwab
Kinsmen Laboratory of Neurological Research, Division of Neurology, University of British Columbia, Vancouver, BC, Canada V6T 1Z3
Exp Neurol 188:52-64. 2004..Therapeutic strategies for the treatment of AD based on tg mouse models that overexpress Abeta may be limited in their application...
Enhancement of immunoreactivity for NF-kappa B in human cerebral infarctionsK Terai
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada
Brain Res 739:343-9. 1996..Capillary staining for NF-kappa B was weak and did not differ significantly between affected and unaffected areas. These results suggest that enhanced expression of astrocytic NF-kappa B occurs in cerebral infarcted areas...
Inhibitory action of 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxam ide (PK 11195) on some mononuclear phagocyte functionsA Klegeris
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, BC, Canada
Biochem Pharmacol 59:1305-14. 2000..Since PK 11195 readily enters the brain, it may be beneficial in treating central as well as peripheral inflammatory diseases...
Toxicity of human THP-1 monocytic cells towards neuron-like cells is reduced by non-steroidal anti-inflammatory drugs (NSAIDs)A Klegeris
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada
Neuropharmacology 38:1017-25. 1999..It is suggested that inhibition of monocyte cytotoxicity might be responsible for the apparent beneficial effects of NSAIDs in Alzheimer's disease...
The pentraxins: possible role in Alzheimer's disease and other innate inflammatory diseasesE G McGeer
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, V6T 1Z3, Vancouver, B C, Canada
Neurobiol Aging 22:843-8. 2001..As such, they may be prime targets for therapeutic intervention...
Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer's diseaseK Terai
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada
Brain Res 735:159-68. 1996..There was no difference between AD and control cases in the staining of glial cells and vascular walls. These results suggest that enhanced expression of neuronal NF-kappa B occurs in areas affected by AD pathology...
Transplantation of cultured human adrenal chromaffin cells into 6-hydroxydopamine-lesioned rat brainH Kamo
Department of Psychiatry, University of British Columbia, Vancouver, Canada
Synapse 1:324-8. 1987..This transplantation of cultured human fetal cells to an animal model may provide the necessary basic experimental system for assessing the possible utility of human neuronal transplants...
Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates beta-amyloid protein activation of complement in vitroP L McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada
Brain Res 749:135-8. 1997..This ApoE4-specific enhancement of complement activation by A beta may relate to its role in increasing the risk of late-onset AD...
Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaquesK Yasojima
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, Vancouver
Arterioscler Thromb Vasc Biol 21:1214-9. 2001..These data indicate that it is primarily the classical, not the alternative pathway, that is activated in plaques and that key inhibitors are not upregulated to defend against this activation...
Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cellsSadayuki Hashioka
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, V6T 1W5 Canada
Neurobiol Aging 30:1924-35. 2009..These findings suggest that activated astrocytes may become neurotoxic when stimulated by IFN-gamma and may therefore exacerbate the pathology in a spectrum of neurodegenerative diseases...
Inflammatory aspects of Alzheimer disease and other neurodegenerative disordersClaudia Schwab
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, BC, Canada
J Alzheimers Dis 13:359-69. 2008..From a therapeutic point of view it is desirable to find methods of tipping the balance towards an anti-inflammatory state for both types of glia...
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptorAndis Klegeris
Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Westbrook Mall, Vancouver, BC, Canada V6T 1Z3
Br J Pharmacol 139:775-86. 2003..5 Specific CB2 receptor ligands could be useful anti-inflammatory agents, while avoiding the neurotoxic and psychoactive effects of CB1 receptor ligands such as Delta(9)-THC...
Brain microglia constitutively express beta-2 integrinsH Akiyama
Department of Psychiatry, Kinsmen Laboratory of Neurological Research, Faculty of Medicine, University of British Columbia, Vancouver, Canada
J Neuroimmunol 30:81-93. 1990..They provide further evidence of an inflammatory response of brain tissue in Alzheimer disease. The microglia were found to make up 9-12% of the total glial population in gray matter and 7.5-9% in white matter...
Microglial response to 6-hydroxydopamine-induced substantia nigra lesionsH Akiyama
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, Vancouver, Canada
Brain Res 489:247-53. 1989..Combined observation of these markers in diseased brain tissue can provide clues as to the stage of the pathology being observed...
Marked increase in cyclooxygenase-2 in ALS spinal cord: implications for therapyK Yasojima
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, Vancouver, Canada
Neurology 57:952-6. 2001..Taken in conjunction with evidence of a neuroprotective effect of COX-2 inhibitors in certain animal models and in organotypic cultures, the data are supportive of a possible future role for COX-2 inhibitors in the treatment of ALS...
beta-amyloid protein enhances macrophage production of oxygen free radicals and glutamateA Klegeris
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada
J Neurosci Res 49:229-35. 1997..Such mechanisms could contribute to the pathogenesis of neurodegenerative disorders, including Alzheimer's disease...
Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brainK Yasojima
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, 2255 Wesbrook Mall, V6T 1Z3, Vancouver, Canada
Brain Res 919:115-21. 2001..Overall, the data indicate that effectiveness of degradation by neprilysin may be a key factor in determining whether Abeta deposits develop...
Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseasesC Schwab
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, B C, Canada
Neurobiol Aging 21:503-10. 2000..The colocalization of the kinase Cki delta and its apparent substrate tau suggests a function for Cki delta in the abnormal processing of tau...
Adhesion of exogenous human microglia and THP-1 cells to amyloid plaques of postmortem Alzheimer's disease brainSadayuki Hashioka
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, The University of British Columbia, Vancouver, BC, Canada
J Alzheimers Dis 14:345-52. 2008..These results suggest that human microglial cells are capable of adhering to and phagocytosing post mortem AD plaque material but activation may be necessary. Astrocytes may further enhance the process...
Modulation of human microglia and THP-1 cell toxicity by cytokines endogenous to the nervous systemAndis Klegeris
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, BC, Canada V6T 1Z3
Neurobiol Aging 26:673-82. 2005..These data suggest that antagonists of cytokine receptors, as well as inhibitors of their intracellular pathways may be effective anti-inflammatory agents...
Proton pump inhibitors exert anti-inflammatory effects and decrease human microglial and monocytic THP-1 cell neurotoxicitySadayuki Hashioka
Department of Psychiatry, Kinsmen Laboratory of Neurological Research, The University of British Columbia, Vancouver, BC, Canada
Exp Neurol 217:177-83. 2009..They suggest that PPIs combined with NSAIDs may be effective in the treatment of a broad spectrum of neurodegenerative diseases associated with activated microglia...
Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activationMoonHee Lee
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, British Columbia, Canada
Glia 58:103-13. 2010....
Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative diseaseAndis Klegeris
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada
Curr Alzheimer Res 2:355-65. 2005..Therefore combination therapy with other anti-inflammatory agents that work through different mechanisms of action might prove to be a superior therapeutic strategy...
S- but not R-enantiomers of flurbiprofen and ibuprofen reduce human microglial and THP-1 cell neurotoxicityAndis Klegeris
Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, Canada V6T 1Z3
J Neuroimmunol 152:73-7. 2004..We found S- but not R-enantiomers to be protective at low concentrations, which is consistent with a COX-dependent mechanism...
Prolyl endopeptidase is revealed following SILAC analysis to be a novel mediator of human microglial and THP-1 cell neurotoxicityAndis Klegeris
Unit of Biology and Physical Geography, Barber School of Arts and Sciences, University of British Columbia Okanagan, Kelowna, British Columbia, Canada
Glia 56:675-85. 2008..We found both to be partially protective in a concentration-dependent manner. Inhibition of PEP may be a therapeutic approach to neurodegenerative disorders including Alzheimer and Parkinson diseases...
Inflammatory processes in amyotrophic lateral sclerosisP L McGeer
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, 2255 Westbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada
Muscle Nerve 26:459-70. 2002..Anti-inflammatory agents may have a role to play in treating ALS. COX-2 is a particularly attractive target because of its marked increase in ALS spinal cord...
Innate immunity in Alzheimer's disease: a model for local inflammatory reactionsE G McGeer
Kinsmen Laboratory of Neurological Research, Department of Psychiatry University of British Columbia, Vancouver, BC V6T 1Z3
Mol Interv 1:22-9. 2001..In the case of Alzheimer's disease, inflammatory processes thus have the potential for turning a relatively slowly progressing condition into one characterized by rapid neurodegeneration...
On the survival time of a tangled neuron in the hippocampal CA4 region in parkinsonism dementia complex of GuamC Schwab
Kinsmen Laboratory of Neurological Research, Movement Disorders Centre, University of B C, Vancouver, Canada
Neurobiol Aging 20:57-63. 1999..The results varied from 0.13 years for the most rapidly progressing case to 7.98 years for the most slowly developing case. The average for 8 cases was 2.51 years...
The importance of inflammatory mechanisms in Alzheimer diseaseE G McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada
Exp Gerontol 33:371-8. 1998..Therapeutic intervention in key inflammatory processes holds great promise for the amelioration of AD and possibly other neurodegenerative disorders...
Converging perturbed microvasculature and microglial clusters characterize Alzheimer disease brainN Jantaratnotai
Department of Anesthesiology, Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia 2176 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada
Curr Alzheimer Res 7:625-36. 2010..Microglial-vascular reciprocal interactions could serve a critical role in the amplification and perpetuation of inflammatory reactivity in AD brain...
Interaction of various intracellular signaling mechanisms involved in mononuclear phagocyte toxicity toward neuronal cellsA Klegeris
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada
J Leukoc Biol 67:127-33. 2000..It is concluded that the stimulants activated multiple intracellular pathways, and that combination therapies inhibiting these pathways might be beneficial for treating neurodegenerative disorders...
Enhancement of progenitor cell division in the dentate gyrus triggered by initial limbic seizures in rat models of epilepsyE Nakagawa
Molecular Neuroscience Research Center, and Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan
Epilepsia 41:10-8. 2000..We investigated which stage of epileptogenesis is critical for eliciting progenitor cell division and whether seizure-induced neuronal degeneration is responsible for the enhancement of progenitor cell division...
Differential expression of interferon-gamma receptor on human glial cells in vivo and in vitroSadayuki Hashioka
Department of Psychiatry, The University of British Columbia, Vancouver, BC, Canada
J Neuroimmunol 225:91-9. 2010....
Increase in core body temperature of Alzheimer's disease patients as a possible indicator of chronic neuroinflammation: a meta-analysisAndis Klegeris
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, BC, Canada
Gerontology 53:7-11. 2007..Such increases have been observed in AD brains. We hypothesized that these increased levels of inflammatory mediators could lead to an increase in core body temperature in AD patients...
Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cellsAndis Klegeris
Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada
FASEB J 20:2000-8. 2006..5 microM respectively. We hypothesize that the neuroinflammation stimulated by release of an excess of normal alpha-synuclein or by release of its mutated forms can be involved in the pathobiology of PD...
Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson diseaseMoonHee Lee
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
J Biol Chem 285:17318-28. 2010..The H(2)S-releasing L-DOPA hybrid molecules also inhibited MAO B activity. They may be useful for the treatment of PD because of their significant antiinflammatory, antioxidant, and neuroprotective properties...
Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxideSadayuki Hashioka
Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Maidashi 3 1 1, Higashi ku, Fukuoka, 812 8582 Japan
Exp Neurol 206:33-42. 2007..On the other hand, the mood stabilizer and anti-manic agent lithium chloride has mixed effects on IFN-gamma-induced microglial activation...
Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseasesMoonHee Lee
Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, Canada V6T 1Z3
FASEB J 24:2533-45. 2010....
Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microgliaAndis Klegeris
Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada
Neurobiol Aging 29:739-52. 2008....
Anti-inflammatory effects of antidepressants: possibilities for preventives against Alzheimer's diseaseSadayuki Hashioka
Department of Psychiatry, The University of British Columbia, Vancouver, Canada
Cent Nerv Syst Agents Med Chem 9:12-9. 2009....
Inflammatory processes in Alzheimer's diseaseEdith G McGeer
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, Canada V6T 1Z3
Prog Neuropsychopharmacol Biol Psychiatry 27:741-9. 2003..These brain phenomena combined with epidemiological evidence of a protective effect of antiinflammatory agents suggest that such agents may have a role to play in treating the disease...
Therapeutic approaches to inflammation in neurodegenerative diseaseAndis Klegeris
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, British Columbia, Canada
Curr Opin Neurol 20:351-7. 2007..Here we review recent advances in our understanding of one such disorder, Parkinson's disease, in which anti-inflammatory drugs are now becoming a new therapeutic focus...
The role of anti-inflammatory agents in Parkinson's diseaseEdith G McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, British Columbia, Canada
CNS Drugs 21:789-97. 2007..Whether such drugs will slow the process of Parkinson's disease or reduce the high risk of dementia in such patients remains to be determined in future work...
Abeta immunotherapy and other means to remove amyloidEdith G McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, B C, Canada
Curr Drug Targets CNS Neurol Disord 4:569-73. 2005..Whether they would affect the more consolidated, cross-linked Abeta of AD and, if they did, whether that would really prove an effective treatment for the disease remains for future research to determine...
Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfideMoonHee Lee
Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, Canada
Neurobiol Aging 30:1523-34. 2009..H(2)S releasing drugs may have therapeutic potential in neurodegenerative disorders of aging such as Alzheimer disease and Parkinson disease...
Inflammation and neurodegeneration in Parkinson's diseasePatrick L McGeer
Kinsmen Laboratory of Neurological Research and the Pacific Parkinson s Research Centre, University of British Columbia, 2255 Westbrook Mall, Vancouver, BC, Canada V6T 1Z3
Parkinsonism Relat Disord 10:S3-7. 2004..The upregulation appears greater than that found in inflamed arthritic joints. These data support the hypothesis that chronic inflammation may play an important role, if secondary, in the pathogenesis of PD...
Familial British dementia: colocalization of furin and ABri amyloidClaudia Schwab
Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada
Acta Neuropathol 106:278-84. 2003..These data suggest that furin may be involved in producing the pathological fragment of ABriPP in vivo and that inhibition of furin might be a method of treating this disorder...
Clinically tested drugs for Alzheimer's diseaseEdith G McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, BC, Canada
Expert Opin Investig Drugs 12:1143-51. 2003..There are some promising leads, but more definitive clinical trials are required. Any agent designed to slow progression should clearly be used at an early stage of the disorder; therefore methods of early diagnosis are also essential...
Is there a future for vaccination as a treatment for Alzheimer's disease?Patrick L McGeer
Department of Psychiatry, University of British Columbia, 2255 Wesbrook Mall, BC, V6T 1Z3, Vancouver, Canada
Neurobiol Aging 24:391-5. 2003..The future of vaccination as a therapy for AD will require surmounting the problems of autoimmune reactions generally and autotoxic complement activation specifically...
Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAPAndis Klegeris
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada
J Leukoc Biol 73:369-78. 2003..The data suggest that inhibition of proinflammatory LT production by 5-LOX inhibition could selectively reduce toxicity of microglial cells and thus be beneficial in neuroinflammatory diseases...
Pharmacologic approaches to the treatment of amyotrophic lateral sclerosisEdith G McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, British Columbia, Canada
BioDrugs 19:31-7. 2005..No breakthrough has yet occurred and present thinking is that combinations of drugs may be required to slow the multifactorial neurodegeneration process effectively...
Anti-inflammatory effects of cerebrocrast in a model of rat paw edema and on mononuclear THP-1 cellsAndis Klegeris
Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, British Columbia, Canada V6T 1Z3
Eur J Pharmacol 441:203-8. 2002....
Chymotrypsin-like proteases contribute to human monocytic THP-1 cell as well as human microglial neurotoxicityAndis Klegeris
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, British Columbia, Canada
Glia 51:56-64. 2005..The data suggest that certain protease inhibitors could inhibit microglial-mediated toxicity. They might represent a novel class of drugs with benefit in diseases where overactivity of microglia contributes to the pathogenesis...
Sparing of age-related macular degeneration in rheumatoid arthritisPatrick L McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada
Neurobiol Aging 26:1199-203. 2005..72%). Patients with RA appear to be relatively spared from AMD. We hypothesize that this results from long term antiinflammatory treatment. Genetic or environmental factors could also be responsible...
Unmasking of an unusual myelin basic protein epitope during the process of myelin degeneration in humans: a potential mechanism for the generation of autoantigensA Matsuo
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada
Am J Pathol 150:1253-66. 1997..If insults occur that repeatedly expose a region of MBP normally sheltered from immunosurveillance, a self-sustaining immune reaction might result...
Inflammation of the brain in Alzheimer's disease: implications for therapyP L McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada
J Leukoc Biol 65:409-15. 1999..Mention will also be made of some recent work on animal models of possible relevance to AD and inflammation...
Immunostaining of human brain capillaries by antibodies to very late antigensP L McGeer
Department of Psychiatry, University of British Columbia, Vancouver, Canada
J Neuroimmunol 26:213-8. 1990..Only residual plasma in vessels was stained with the antibody to fibronectin. Negative staining was obtained with antibodies to the fibronectin receptor VLA-5 and VLA-3. Trace staining was obtained with the antibody to VLA-2...
Expression of complement C4 and C9 genes by human astrocytesD G Walker
Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
Brain Res 809:31-8. 1998..In addition it was shown that stimulated astrocytes could also express complement C9 mRNA, though C9 protein was not detectable in culture supernatants...
The possible role of complement activation in Alzheimer diseasePatrick L McGeer
Kinsmen Laboratory of Neurological Research, Dept of Psychiatry, University of British Columbia, 2255 Wesbrook Mall, BC, V6T 1Z3, Vancouver, Canada
Trends Mol Med 8:519-23. 2002..Overactive microglia secrete many toxic materials. Inhibition of microglial activation is another potential therapeutic target...
Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brainTetsuaki Arai
Department of Psychiatry, Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, BC, Canada
J Neuropathol Exp Neurol 65:19-25. 2006..The accumulation of thrombin and prothrombin in NFTs supports the hypothesis that thrombin may be involved in tau proteolysis and that failure to metabolize tau may lead to its aggregation in neurodegenerative diseases...
Inflammation in transgenic mouse models of neurodegenerative disordersClaudia Schwab
Department of Psychiatry, Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC V6T1Z3, Canada
Biochim Biophys Acta 1802:889-902. 2010..In particular, the mouse models of Alzheimer disease have also led to the development of new therapeutic strategies such as vaccination and modulation of microglial activity...
LRRK2 expression in normal and pathologic human brain and in human cell linesJudith Miklossy
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, BC, Canada
J Neuropathol Exp Neurol 65:953-63. 2006..In summary, LRRK2 is constitutively expressed in neurons and also in glial cells of human brain. It strongly associates with pathological inclusions in several neurodegenerative disorders...
Inflammation, the complement system and the diseases of agingEdith G McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, Canada
Neurobiol Aging 26:94-7. 2005..Stimulation is provided by a variety of inflammatory cytokines. Agents which reduce the intensity of inflammation should have broad spectrum application in degenerative diseases of aging...
Lrrk2 and chronic inflammation are linked to pallido-ponto-nigral degeneration caused by the N279K tau mutationJudith Miklossy
Kinsmen Laboratory of Neurological Research, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, Canada, V6T 1Z3
Acta Neuropathol 114:243-54. 2007..The results indicate that Lrrk2 is linked to frontotemporal atrophy of PPND type caused by N279K tau mutation. They also show that chronic inflammation is involved in the pathogenesis of N279K/FTDP-17/PPND...
gamma-Glutamyltransferase activity is unchanged in acutely quinolinate-lesioned rat neostriatum but is elevated in Huntington's disease caudateS G Zhu
Department of Psychiatry, University of British Columbia, Vancouver
Exp Neurol 107:106-9. 1990..The chronicity of the degenerative disease, contrasted with the acuteness of the lesion, may explain the difference...
Up-regulated production and activation of the complement system in Alzheimer's disease brainK Yasojima
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, British Columbia, Canada
Am J Pathol 154:927-36. 1999....
Lrrk2 interaction with alpha-synuclein in diffuse Lewy body diseaseHong Qing
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3
Biochem Biophys Res Commun 390:1229-34. 2009..New therapeutic approaches to PD and the synucleinopathies may result from limiting the interaction between Lrrk2 and alpha-synuclein...
Localization and possible functions of presenilins in brainP L McGeer
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada
Rev Neurosci 9:1-15. 1998..The functions of the presenilins are not yet known, but available evidence points to pyramidal neurons as the most logical site for pathological change in AD...
